About Us

Etain is a New York and women founded cannabis company. As one of New York’s original five cannabis licensees, Etain has served New York’s medical cannabis patients since 2015 and now serves the adult-use market as well. Etain has cultivation and manufacturing operations in Warren County and dispensaries in White Plains, Kingston, Syracuse, and Midtown East in New York City. True to its founding, Etain maintains its commitment to elevating women in cannabis with Etain dispensaries carrying a curated selection of women-owned cannabis and wellness brands. To learn more, visit www.etainhealth.com.

Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 18 U.S. jurisdictions and the EU. Columbia Care operates 130 facilities including 99 dispensaries and 31 cultivation and manufacturing facilities, including those under development. Columbia Care is one of the original providers of medical cannabis in the U.S. and now delivers industry-leading products and services to both the medical and adult-use markets. In 2021, the company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils, and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, gLeaf, Classix, Plant Sugar, Press, Amber and Platinum Label CBD. For more information on Columbia Care, please visit www.col-care.com.

Cresco Labs is one of the most trusted and fastest growing cannabis companies. With dispensaries in Williamsburg, Brooklyn and Huntington, Long Island, Cresco Cresco entered the New York market with four strategically located dispensaries. From careful cultivation to consistent distribution, they provide a portfolio of brands thoughtfully made for every patient. Cresco products provide safe, consistent, and trusted alternatives to traditional pharmaceuticals like opioids. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco has launched a comprehensive Social Equity and Educational Development (SEED) initiative designed to ensure that all members of society have the skills, knowledge and opportunity to work in and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.

Curaleaf NY began its operations in April 2018 and currently operates four dispensaries in New York in the North Country, Hudson Valley, Queens and Nassau County. As a health and wellness company, Curaleaf’s mission is to help patients live life well by providing them with high-quality medical cannabis at affordable prices. Curaleaf's state of the art cultivation and manufacturing facility located just outside of Albany was approved by state Health Department and began manufacturing Curaleaf medicines in August 2018. 

Since its inception, Curaleaf has contributed nearly $500,000 in compassionate care assistance to economically disadvantaged patients and veterans. The company forged new ground in the state with its innovative, affordable products and is the only cannabis operator to make whole plant available to its patients in the form of ground flower pods. In addition, Curaleaf is the first company to offer medical cannabis gel tablets for patients who are seeking a new method of administration. Learn more at https://ny.curaleaf.com/.

Green Thumb Industries (GTI) is a cannabis cultivator, processor, and dispensary operator dedicated to providing dignified access to safe and effective cannabis, while giving back to the communities in which they serve. Earlier this year GTI  acquired New York-based Fiorello Pharmaceuticals, one of only 10 companies approved to operate a medical cannabis company in the state. Assets include a manufacturing and cultivation facility in Schenectady County and a retail store in each of the following locations: Manhattan, Rochester, Halfmoon and Nassau County, three of which are open. More information is available at GTIgrows.com.

Acreage is a multi-state operator of cannabis ‎cultivation and retailing facilities in the U.S., including the company’s national retail store ‎brand, The Botanist. With its principal address in New York City, Acreage’s wide range of national and regionally available cannabis products include the award-winning The Botanist brand, craft brand Superflux, the Tweed brand, the Prime medical brand in Pennsylvania, the Innocent brand in Illinois and others. Acreage also owns Universal Hemp, LLC, a hemp subsidiary dedicated to the distribution, marketing and sale of CBD products throughout the U.S. Since its founding in 2011, Acreage has focused on building and scaling operations to create a ‎seamless, consumer-focused, branded experience. Learn more at www.acreageholdings.com and follow us on Twitter, LinkedIn, Instagram, and Facebook.

iAnthus Capital Holdings, Inc. owns and operates best-in-class licensed cannabis cultivation, processing and dispensary facilities throughout the United States, providing investors diversified exposure to the U.S. regulated cannabis industry. Founded by entrepreneurs with decades of experience in operations, investment banking, corporate finance, law and health care services, iAnthus provides a unique combination of capital and hands-on operating and management expertise. iAnthus currently has a presence in 11 states, including 30 dispensaries (FL-12, AZ-4, MA-1, MD-3, NY-2, CO-1, VT-1 and NM-6 where iAnthus has minority ownership). For more information, visit www.iAnthus.com.

PharmaCann LLC is one of the largest private cannabis providers in the nation, with 13 dispensary locations and three production facilities currently operating across multiple states. PharmaCann offers pharmaceutical grade cannabis products to customers looking to improve the quality of their lives. For more information about PharmaCann, please visit www.pharmacann.com.

Vireo Health International, Inc.’s mission is to build the cannabis company of the future by bringing the best of medicine, engineering and science to the cannabis industry. Vireo’s physician-led team of nearly 400 employees provides best-in-class cannabis products and customer experience. Vireo cultivates cannabis in environmentally-friendly greenhouses, manufactures pharmaceutical-grade cannabis extracts, and sells its products at both company-owned and third-party dispensaries. The Company is currently licensed in eleven markets including Arizona, Maryland, Massachusetts, Minnesota, Nevada, New Mexico, New York, Ohio, Pennsylvania, Puerto Rico, and Rhode Island. For more information about the company, please visit www.vireohealth.com.